Wiktionary
alisertib
n. An orally available selective aurora A kinase inhibitor being investigated as a treatment for relapsed or refractory peripheral T-cell lymphoma.
Wikipedia
Alisertib
Alisertib (MLN8237) is an orally available selective aurora A kinase inhibitor developed by Takeda. It is currently being investigated as a treatment for relapsed or refractory peripheral T-cell lymphoma.